Paul Matteis
Stock Analyst at Stifel
(0)
# 3838
Out of 5,298 analysts
138
Total ratings
29.82%
Success rate
-6.05%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ALNY Alnylam Pharmaceutic... | Maintains: Strong Buy | 300 345 | 249.66 | 38.19% | 13 | Mar 31, 2025 | |
NMRA Neumora Therapeutics | Downgrades: Hold | 6 2 | 0.77 | 159.74% | 2 | Mar 7, 2025 | |
RYTM Rhythm Pharmaceutica... | Reinstates: Buy | 78 | 48.14 | 62.03% | 1 | Mar 5, 2025 | |
SION Sionna Therapeutics | Initiates Coverage On: Buy | 32 | 11.32 | 182.69% | 1 | Mar 4, 2025 | |
CMPS Compass Pathways | Initiates Coverage On: Buy | 11 | 2.69 | 308.92% | 1 | Feb 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 18 32 | 9.62 | 232.64% | 2 | Feb 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 490 494 | 490.43 | 0.73% | 18 | Dec 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 12 32 | 9.17 | 248.96% | 1 | Dec 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 10 6 | 7.24 | -17.13% | 5 | Dec 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 4 | 1.06 | 277.36% | 4 | Dec 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 32 10 | 1.74 | 474.71% | 3 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 44 60 | 8.96 | 569.64% | 2 | Nov 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 25 36 | 30.62 | 17.57% | 7 | Nov 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 115 87 | 63.99 | 35.96% | 8 | Sep 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 41 66 | 8.63 | 664.77% | 3 | Aug 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | 8.32 | 320.67% | 1 | Jul 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 50 53 | 28.01 | 89.22% | 5 | Jun 27, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 26 21 | 15.72 | 33.59% | 5 | May 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 29 | 5.98 | 384.95% | 1 | Apr 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 141 144 | 96.65 | 48.99% | 8 | Dec 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 315 287 | 127.09 | 125.82% | 6 | Dec 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | 2.46 | 713.01% | 1 | Nov 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 2.21 | 442.99% | 1 | Nov 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 24 | 1.1 | 2081.82% | 2 | Jun 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 260 295 | n/a | n/a | 4 | Sep 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 50 54 | n/a | n/a | 2 | Aug 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 36 5 | 0.27 | 1751.85% | 2 | Jun 23, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 54 32 | 10.51 | 204.47% | 1 | Jun 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 24 | 1.62 | 1381.48% | 1 | Feb 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | n/a | n/a | 1 | Sep 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 27 | 0.96 | 2712.5% | 1 | Jul 26, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 23 23 | n/a | n/a | 2 | Dec 17, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 150 140 | n/a | n/a | 7 | Jul 15, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 14 | 6.8 | 105.88% | 1 | Mar 12, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 60 | n/a | n/a | 6 | Nov 13, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 3000 2280 | n/a | n/a | 1 | Oct 5, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 25 31 | n/a | n/a | 2 | Sep 25, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 17 18 | n/a | n/a | 2 | Feb 27, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 53 64 | 6.32 | 912.66% | 1 | Feb 21, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 28 22 | n/a | n/a | 2 | Oct 9, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 340 | 16.84 | 1919% | 1 | Dec 21, 2016 |